Bradshaw CS. Complexity, Challenges, Change in Sexual Health. MG update on resistant guided care, AChSHM ASM 2021 3/2021
Bradshaw CS. Mycoplasma genitalium Update. Royal Australian College of General Practitioners 3/2021
Bradshaw CS. M.genitalium: When to test and when to treat, Invited Webinar Series of International Union for STIs 6/2021
Bradshaw CS: New treatment approaches for M.genitalium: STI and HIV World Congress 7/2021
Bradshaw CS: Resistance-guided therapy for M.genitalium: STI and HIV World Congress 7/2021
Bradshaw CS: Mycoplasma genitalium: Australasian Society for HIV Medicine and Australasian Chapter of Sexual Health Update. 7/2021
Bradshaw CS: Mycoplasma genitalium: Where to next? Australasian Sexual Health Conference, 9/021
Bradshaw CS: Clinical problems, scientific solutions. Mycoplasma genitalium – our emerging STI superbug. MIDS & The Centre to Impact AMR. Inaugural joint GRAND ROUNDS Event. Alfred Hospital, 10/2021
Bradshaw CS: Mycoplasma genitalium: Approaches to testing and treatment. 26th Annual Scientific Session of the Sri Lanka College of Sexual Health and HIV medicine, 12/2021
Bradshaw CS. Plenary: M. genitalium Clinical Care – Resistance-Guided Treatment 21st World Congress of the International Union against STIs, 12/2021
Bradshaw CS Implementation of STI point of care testing. AChSHM Annual Scientific Meeting, 19 March 2022.
Bradshaw CS: Molecular-guided therapy for Mycoplasma genitalium, European Society of Clinical Microbiology and Infectious Diseases, 4/2022
Bradshaw CS. Mycoplasma genitalium: evidence to inform testing and treatment University of Washington, Seattle USA, Research Seminar Series, 5/2022
Bradshaw CS: Latest science, resistance, and recommendations for treatment of Mycoplasma genitalium. American Society for Microbiology, Washington DC, USA. 6/2022.